Index RUT
P/E -
EPS (ttm) -1.32
Insider Own 13.84%
Shs Outstand 156.65M
Perf Week -8.75%
Market Cap 1.44B
Forward P/E -
EPS next Y -1.06
Insider Trans -0.23%
Shs Float 135.46M
Perf Month -13.15%
Income -174.34M
PEG -
EPS next Q -0.25
Inst Own 77.39%
Short Float 7.96%
Perf Quarter 9.42%
Sales 61.44M
P/S 23.49
EPS this Y -16.28%
Inst Trans 2.43%
Short Ratio 9.22
Perf Half Y 76.54%
Book/sh 2.25
P/B 4.09
EPS next Y 9.93%
ROA -53.42%
Short Interest 10.78M
Perf Year 156.42%
Cash/sh 2.72
P/C 3.38
EPS next 5Y -
ROE -96.89%
52W Range 3.24 - 11.77
Perf YTD 105.83%
Dividend Est. -
P/FCF -
EPS past 5Y 8.38%
ROI -40.98%
52W High -22.04%
Beta 1.20
Dividend TTM -
Quick Ratio 12.94
Sales past 5Y 121.20%
Gross Margin 90.59%
52W Low 182.90%
ATR (14) 0.56
Dividend Ex-Date -
Current Ratio 13.01
EPS Y/Y TTM -52.56%
Oper. Margin -229.90%
RSI (14) 42.26
Volatility 4.94% 6.02%
Employees 267
Debt/Eq 0.21
Sales Y/Y TTM 6.45%
Profit Margin -283.74%
Recom 1.11
Target Price 18.22
Option/Short Yes / Yes
LT Debt/Eq 0.21
EPS Q/Q 13.74%
Payout -
Rel Volume 0.63
Prev Close 9.48
Sales Surprise -9.94%
EPS Surprise 9.35%
Sales Q/Q 2.28%
Earnings Nov 14 BMO
Avg Volume 1.17M
Price 9.18
SMA20 -5.15%
SMA50 -8.36%
SMA200 11.46%
Trades
Volume 732,433
Change -3.16%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-16-24 Initiated
Scotiabank
Sector Outperform
Jun-20-24 Upgrade
TD Cowen
Hold → Buy
$7 → $11
May-31-24 Resumed
Piper Sandler
Overweight
$15
Feb-09-24 Initiated
BofA Securities
Buy
$15
Apr-21-23 Initiated
Robert W. Baird
Outperform
$18
Aug-10-22 Resumed
Berenberg
Buy
$15
Aug-10-21 Upgrade
H.C. Wainwright
Neutral → Buy
$17
Dec-28-20 Downgrade
H.C. Wainwright
Buy → Neutral
Dec-17-20 Initiated
Berenberg
Buy
$27
Nov-13-20 Reiterated
Raymond James
Strong Buy
$15 → $25
Aug-10-20 Reiterated
H.C. Wainwright
Buy
$10 → $13
Mar-03-20 Upgrade
Raymond James
Outperform → Strong Buy
May-21-19 Reiterated
H.C. Wainwright
Buy
$12 → $9
May-21-19 Downgrade
Raymond James
Strong Buy → Outperform
$11 → $5
May-21-19 Downgrade
Cowen
Outperform → Market Perform
$13 → $3
Dec-03-18 Reiterated
Cantor Fitzgerald
Overweight
$22 → $24
Nov-15-18 Initiated
Raymond James
Strong Buy
$10
Sep-07-18 Initiated
Piper Jaffray
Overweight
Oct-24-17 Initiated
Guggenheim
Buy
$12
Jul-26-17 Initiated
H.C. Wainwright
Buy
$10
Show Previous Ratings
Dec-03-24 07:47AM
Dec-02-24 07:30AM
Nov-26-24 07:30AM
Nov-15-24 02:06AM
Nov-14-24 08:40AM
07:37AM
Loading…
07:37AM
(Associated Press Finance)
07:00AM
Nov-13-24 07:30AM
07:17AM
Nov-12-24 07:30AM
Nov-06-24 07:30AM
Oct-15-24 07:30AM
Oct-14-24 09:59AM
Oct-09-24 04:05PM
07:30AM
08:50AM
Loading…
Oct-08-24 08:50AM
Sep-25-24 07:30AM
Sep-12-24 04:05PM
Sep-05-24 07:30AM
Sep-04-24 07:30AM
Aug-09-24 09:55AM
07:30AM
Aug-07-24 08:45AM
07:38AM
(Associated Press Finance)
07:10AM
07:00AM
Jul-31-24 07:30AM
Jul-30-24 07:30AM
Jul-18-24 04:05PM
Jul-10-24 08:00AM
04:05PM
Loading…
Jul-08-24 04:05PM
Jun-13-24 04:05PM
Jun-05-24 07:30AM
Jun-04-24 04:05PM
May-07-24 09:01PM
06:07PM
04:41PM
(Associated Press Finance)
04:05PM
May-06-24 08:16PM
07:30AM
May-03-24 07:30AM
May-01-24 07:30AM
Apr-24-24 08:30AM
Apr-18-24 03:37PM
07:00AM
Apr-16-24 04:30PM
07:00AM
Apr-15-24 07:00AM
Apr-09-24 09:35AM
07:30AM
Apr-06-24 10:00AM
Apr-01-24 10:09AM
Mar-26-24 07:30AM
Mar-13-24 06:38AM
(Thomson Reuters StreetEvents)
Mar-12-24 09:55AM
Mar-11-24 05:32PM
05:25PM
04:26PM
(Associated Press Finance)
04:05PM
Mar-05-24 07:30AM
Mar-01-24 06:30PM
Feb-29-24 08:52AM
Feb-28-24 01:40PM
Feb-26-24 12:00PM
10:00AM
Feb-25-24 02:02PM
Feb-22-24 07:32AM
07:31AM
07:30AM
Feb-21-24 09:55AM
Feb-19-24 09:00AM
Feb-18-24 08:00PM
Feb-15-24 08:00AM
Feb-13-24 07:37AM
Feb-12-24 06:27AM
Jan-30-24 09:55AM
Jan-25-24 08:00AM
Jan-10-24 08:44AM
Jan-03-24 01:15PM
Dec-18-23 04:01PM
(GlobeNewswire) -6.74%
+10.23%
Dec-13-23 10:09PM
04:01PM
Nov-08-23 05:18PM
(Insider Monkey) -13.20%
-13.39%
08:00AM
Nov-07-23 06:47PM
(Associated Press Finance)
04:01PM
Nov-01-23 08:00AM
07:06AM
Oct-31-23 09:00AM
Oct-30-23 09:35PM
Oct-24-23 08:00AM
Oct-03-23 04:01PM
Sep-19-23 09:00PM
Sep-06-23 08:00AM
Aug-09-23 08:00AM
Aug-08-23 11:13AM
(Thomson Reuters StreetEvents) -10.78%
Aug-07-23 07:15PM
06:05PM
(Associated Press Finance)
04:01PM
Jul-24-23 08:00AM
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Heier Jeffrey S. Chief Scientific Officer Nov 25 '24 Sale 9.01 2,948 26,561 269,059 Nov 27 07:52 AM Kaiser Peter Chief Development Officer Nov 25 '24 Sale 9.01 2,897 26,102 213,087 Nov 27 07:51 AM Nayak Sanjay Chief Strategy Officer Nov 25 '24 Sale 9.00 1,814 16,326 174,380 Nov 27 07:49 AM Dugel Pravin See Remarks Nov 25 '24 Sale 9.01 20,680 186,327 791,793 Nov 27 07:47 AM SANJAY NAYAK Officer Nov 25 '24 Proposed Sale 8.97 1,814 16,273 Nov 25 06:42 PM PETER KAZUO KAISER Officer Nov 25 '24 Proposed Sale 9.01 2,897 26,095 Nov 25 06:23 PM PRAVIN DUGEL Officer Nov 25 '24 Proposed Sale 9.01 17,783 160,186 Nov 25 06:19 PM PRAVIN DUGEL Officer Nov 25 '24 Proposed Sale 9.01 2,897 26,095 Nov 25 05:44 PM JEFFREY S. HEIER Officer Nov 25 '24 Proposed Sale 9.01 2,948 26,550 Nov 25 05:10 PM PHILIP C. STRASSBURGER Officer Oct 16 '24 Proposed Sale 10.23 13,125 134,269 Oct 16 04:25 PM Nayak Sanjay Chief Strategy Officer Aug 23 '24 Sale 9.02 1,832 16,525 176,194 Aug 27 05:19 PM Dugel Pravin See Remarks Aug 23 '24 Sale 9.02 20,880 188,338 812,473 Aug 27 05:17 PM RABIA OZDEN Officer Aug 27 '24 Proposed Sale 9.00 18,333 164,997 Aug 27 04:18 PM PRAVIN DUGEL Officer Aug 23 '24 Proposed Sale 9.02 20,880 188,271 Aug 23 05:10 PM SANJAY NAYAK Officer Aug 23 '24 Proposed Sale 9.02 1,832 16,526 Aug 23 04:36 PM RABIA OZDEN Officer Aug 21 '24 Proposed Sale 8.90 10,000 89,047 Aug 21 05:32 PM RABIA OZDEN Officer Aug 07 '24 Proposed Sale 8.50 15,000 127,500 Aug 07 04:15 PM ANTONY MATTESSICH Former Officer Aug 01 '24 Proposed Sale 8.19 23,979 196,498 Aug 01 04:30 PM LINDSTROM RICHARD L MD Director Feb 27 '24 Option Exercise 8.80 30,302 266,658 150,704 Jul 26 07:30 PM Nayak Sanjay Chief Strategy Officer May 23 '24 Sale 5.84 2,274 13,280 178,026 May 28 05:01 PM Dugel Pravin See Remarks May 23 '24 Sale 5.79 21,626 125,215 833,353 May 28 05:00 PM SUMMER ROAD LLC 10% Owner Feb 26 '24 Buy 7.52 930,851 7,000,000 8,591,401 Feb 27 04:43 PM Notman Donald Chief Financial Officer Jan 31 '24 Sale 4.95 6,433 31,843 139,932 Feb 02 07:03 PM Ozden Rabia Gurses Chief Medical Officer Jan 31 '24 Sale 4.95 7,764 38,432 92,767 Feb 02 07:02 PM Strassburger Philip C. General Counsel Jan 31 '24 Sale 4.95 6,831 33,813 109,218 Feb 02 07:01 PM White Christopher G Chief Business Officer Jan 31 '24 Sale 4.95 5,147 25,478 89,619 Feb 02 07:01 PM Mattessich Antony C. President and CEO Jan 31 '24 Sale 4.95 18,338 90,773 427,943 Feb 02 07:00 PM SUMMER ROAD LLC 10% Owner Dec 14 '23 Buy 3.25 1,538,461 4,999,998 7,660,550 Dec 18 04:52 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite